Intervju med Refine Groups VD David Wallinder
Video
2024-06-28
Kommentar
2024-06-26
Comment on ODI Pharma’s Strategic Market Entry to Switzerland
Analys
2024-06-18
Refine Group
Syncro Group Q1-24
Vultus